Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Case Report

Aleukemic Leukemia Cutis Presenting as a Sole Sign of Relapsed Paediatric Acute Lymphoblastic Leukemia

Authors: Kshitij Joshi, Harsha Panchal, Sonia Parikh, Gaurang Modi, Avinash Talele, Asha Anand, Urmila Uparkar, Nitin Joshi, Itesh Khatawani

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

The author describes paediatric case of relapsed acute lymphoblastic leukaemia (ALL) presented as aleukemic leukaemia cutis (ALC). A 2 year old child was admitted in tertiary oncology centre. He suffered from pre B cell ALL with absent Philadelphia chromosome. This patient received multiagent induction chemotherapy as per Berlin–Frankfurt–Munster (BFM) protocol for ALL. He achieved remission after 28 days of treatment. Subsequently he presented with multiple skin lesions in the form of multiple small erythematous violaceous macules, papules, plaques and nodules on face, chest and back regions. Histopathological examination of biopsy of skin revealed diffuse infiltration of tumor cells with prominent nucleoli, scant eosinophilic cytoplasm and numerous mitotic figures consistent with LC. Immunohistochemistry was positive for CD 10, CD 19, CD 22, CD 24, CD 79-a and TdT while negative for surface immunoglobulin. At the time of presentation his peripheral blood smear and bone marrow examination was negative for malignant cells. Sanctuary sites including central nervous system and testicles were not involved. So patient was diagnosed as ALC. He was managed as per BFM relapse protocol for ALL. Skin lesions disappeared completely after 2 weeks of treatment. Unfortunately patient developed bone marrow and testicular relapse after 2 months. He was given testicular radiotherapy and systemic chemotherapy for relapsed ALL. But his marrow was showing persistent activity and he expired after 4 months.
Literature
1.
go back to reference Su WP (1994) Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis. Semin Dermatol 3:223–230 Su WP (1994) Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis. Semin Dermatol 3:223–230
2.
go back to reference Wagner G, Fenchel K, Back W et al (2012) Leukemia cutis: epidemiology, clinical presentation, and differential diagnosis. J Dtsch Dermatol Ges 10:27–36PubMed Wagner G, Fenchel K, Back W et al (2012) Leukemia cutis: epidemiology, clinical presentation, and differential diagnosis. J Dtsch Dermatol Ges 10:27–36PubMed
3.
4.
go back to reference Sander CA, Medeiros LJ, Abruzzo LV et al (1991) Lymphoblastic lymphoma presenting in cutaneous sites: a clinicopathologic analysis of six cases. J Am Acad Dermatol 25:1023–1031CrossRefPubMed Sander CA, Medeiros LJ, Abruzzo LV et al (1991) Lymphoblastic lymphoma presenting in cutaneous sites: a clinicopathologic analysis of six cases. J Am Acad Dermatol 25:1023–1031CrossRefPubMed
6.
go back to reference Rizzani C, Valsecchi MG et al (2004) outcome of very late relapse in children with ALL. Haematologica 89(4):427–434 Rizzani C, Valsecchi MG et al (2004) outcome of very late relapse in children with ALL. Haematologica 89(4):427–434
7.
go back to reference Millot F, Robert A, Bertrand Y et al (1997) Cutaneous involvement in children with ALL or lymphoblastic lymphoma: the Children’s Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC). Pediatrics 100:60–64CrossRefPubMed Millot F, Robert A, Bertrand Y et al (1997) Cutaneous involvement in children with ALL or lymphoblastic lymphoma: the Children’s Leukemia Cooperative Group of the European Organization of Research and Treatment of Cancer (EORTC). Pediatrics 100:60–64CrossRefPubMed
8.
go back to reference Stawiski MA (1978) Skin manifestations of leukemias and lymphomas. Cutis 21:814–818PubMed Stawiski MA (1978) Skin manifestations of leukemias and lymphomas. Cutis 21:814–818PubMed
10.
go back to reference Bakst RL, Tallman MS et al (2011) How I treat extramedullary acute myeloid leukemia. Blood 118(14):3785–3793CrossRefPubMed Bakst RL, Tallman MS et al (2011) How I treat extramedullary acute myeloid leukemia. Blood 118(14):3785–3793CrossRefPubMed
12.
go back to reference Najem N, Zadeh V, Badawi M et al (2011) Aleukemic leukemia cutis in a child pre ceding T-cell acute lymphoblastic leukemia. Pediatr Dermatol 28:535–537CrossRefPubMed Najem N, Zadeh V, Badawi M et al (2011) Aleukemic leukemia cutis in a child pre ceding T-cell acute lymphoblastic leukemia. Pediatr Dermatol 28:535–537CrossRefPubMed
13.
go back to reference Taniguchi S, Hamada T, Kutsuna H et al (1996) Lymphocytic aleukemic leukemia cutis. J Am Acad Dermatol 35:849–850CrossRefPubMed Taniguchi S, Hamada T, Kutsuna H et al (1996) Lymphocytic aleukemic leukemia cutis. J Am Acad Dermatol 35:849–850CrossRefPubMed
14.
go back to reference Kishimoto H, Furui Y, Nishioka K (2001) B-cell ALL with a leukemic leukemia cutis. Eur J Dermatol 11:151–152PubMed Kishimoto H, Furui Y, Nishioka K (2001) B-cell ALL with a leukemic leukemia cutis. Eur J Dermatol 11:151–152PubMed
15.
go back to reference Cochrane T, Milne JA (1974) A leukaemic acute lymphoblastic leukaemia presenting with cutaneous lesions. Br J Dermatol 91:587–589CrossRefPubMed Cochrane T, Milne JA (1974) A leukaemic acute lymphoblastic leukaemia presenting with cutaneous lesions. Br J Dermatol 91:587–589CrossRefPubMed
16.
go back to reference Ali R, Ozan U, Ozkalemkas F et al (2006) Leukaemia cutis in T-cell acute lymphoblastic leukaemia. Cytopathology 17:158–161CrossRefPubMed Ali R, Ozan U, Ozkalemkas F et al (2006) Leukaemia cutis in T-cell acute lymphoblastic leukaemia. Cytopathology 17:158–161CrossRefPubMed
17.
go back to reference Aneta S, Jakub L, Joanna Z et al (2014) Aleukemic leukemia cutis as a manifestation of acute lymphoblastic leukemia in a 13-year-old girl. Prog Med Sci 27(4):271–274 Aneta S, Jakub L, Joanna Z et al (2014) Aleukemic leukemia cutis as a manifestation of acute lymphoblastic leukemia in a 13-year-old girl. Prog Med Sci 27(4):271–274
18.
go back to reference Leah H, Jayesh M, Jonathan C et al (2013) Recurrent aleukemic leukemia cutis in a patient with pre-B-cell acute lymphoblastic leukemia. J Clin Oncol 31:353–355CrossRef Leah H, Jayesh M, Jonathan C et al (2013) Recurrent aleukemic leukemia cutis in a patient with pre-B-cell acute lymphoblastic leukemia. J Clin Oncol 31:353–355CrossRef
19.
go back to reference Kishimoto H, Furui Y, Nishioka K (2001) B-cell ALL with a leukemic leukemia cutis. Eur J Dermatol 11:151–152PubMed Kishimoto H, Furui Y, Nishioka K (2001) B-cell ALL with a leukemic leukemia cutis. Eur J Dermatol 11:151–152PubMed
Metadata
Title
Aleukemic Leukemia Cutis Presenting as a Sole Sign of Relapsed Paediatric Acute Lymphoblastic Leukemia
Authors
Kshitij Joshi
Harsha Panchal
Sonia Parikh
Gaurang Modi
Avinash Talele
Asha Anand
Urmila Uparkar
Nitin Joshi
Itesh Khatawani
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0597-z

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine